Pharmacokinetics of iron isomaltoside 1000 in patients with inflammatory bowel disease

Kim Nordfjeld, Hans Andreasen, Lars L ThomsenPharmacosmos A/S, Holbaek, DenmarkBackground: Iron isomaltoside 1000 is a novel injectable iron compound which offers potential advantages in the treatment of subjects with iron-deficiency anemia. We studied the pharmacokinetics (PK) of this novel compoun...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Nordfjeld K (Egilea), Andreasen H (Egilea), Thomsen LL (Egilea)
Formatua: Liburua
Argitaratua: Dove Medical Press, 2012-03-01T00:00:00Z.
Gaiak:
Sarrera elektronikoa:Connect to this object online.
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Internet

Connect to this object online.

3rd Floor Main Library

Aleari buruzko argibideak 3rd Floor Main Library
Sailkapena: A1234.567
Alea 1 Eskuragarri